Use of Bv8 and/or EG-VEGF to promote hematopoiesis
Details for Australian Patent Application No. 2004219592 (hide)
International Classifications
Event Publications
25 August 2005 PCT application entered the National Phase
PCT publication WO2004/081229 Priority application(s): WO2004/081229
29 July 2010 Application Accepted
Published as AU-B-2004219592
4 November 2010 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 11 Oct 2010. Address for service in Australia - Griffith Hack Level 3 509 St Kilda Road Melbourne VIC 3004
24 February 2011 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 11 Oct 2010
3 March 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004219595-Formulations for cellschedule dependent anticancer agents
2004219584-Approaches to identifying genetic traits in animals
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser